Using simulated scenarios to train front-line staff in the COVID-19 response
The Oxford Simulation, Teaching and Research Centre has been busier than ever during the coronavirus pandemic
Read moreUsing MRI to investigate the effect of COVID-19 on the brain
A team of our neuroimaging researchers will lead this study, which has received a grant from the University of Oxford's COVID-19 Research Response Fund.
Read moreCOVID-19 drug trial could lead to enhanced respiratory care for patients
Researchers including Stuart McKechnie and Matthew Rowland from our Critical Care Research Group are carrying out a new drug trial aimed at treating COVID-19, funded by LifeArc.
Read moreUsing wearable technology to monitor COVID-19 patients
System being used in John Warin isolation ward at Oxford's John Radcliffe Hospital
Read moreOxford leads part of major COVID-19 drugs trial
As part of the UK NIHR multi-arm, multi-stage CATALYST Trial, researchers at the University of Oxford will investigate whether administering the anti-inflammatory drug infliximab to patients with COVID-19 can prevent progression to respiratory failure or death.
Read moreEffects of COVID-19 on sleep: Oxford researchers lead international study
An international group of researchers led by Professor Colin Espie is investigating the impact of the COVID-19 pandemic on sleep and daily rhythms in adults.
Read moreFrom our Head of Department
Welcome to the Nuffield Department of Clinical Neurosciences (NDCN), one of the World's leading centres for research and treatment in disorders of the nervous system.
Take part in our research
Coronavirus Research
Work with us
What's new
Recent DPhil student begins fellowship to study causes of motor neuron disease
28 July 2020
The Medical Research Council has awarded Alexander Thompson a prestigious five-year Lady Edith Wolfson MRC Clinician Scientist Fellowship to investigate the causes of amyotrophic lateral sclerosis (ALS, also known as motor neuron disease, MND).
Professor Robert MacLaren receives Innovation Award
27 July 2020
Professor Robert MacLaren is the winner of the Inspiring Leadership category in the Vice-Chancellor's Innovation Awards 2020 for his work on Nightstar, a retinal gene therapy company.
Seminar Summary: Interventions for improving chronic sleep disruption
22 July 2020
DPhil student Lampros Bisdounis summarises a departmental seminar by Associate Professor Simon Kyle
Six-month outcomes after treatment for COVID-19 on intensive care units in England
21 July 2020
Researchers at the University of Oxford are investigating the long-term health outcomes for patients who have been treated for severe COVID-19 disease in intensive care. Finding out whether these outcomes differ from those of other patients who have survived critical care will help to inform clinical practice and appropriate follow-up care.
AT A GLANCE
Events
